As of Aug 30
| -0.0213 / -3.54%|
The 2 analysts offering 12-month price forecasts for CytRx Corp have a median target of 1.88, with a high estimate of 3.00 and a low estimate of 0.75. The median estimate represents a +223.28% increase from the last price of 0.58.
The current consensus among 2 polled investment analysts is to Buy stock in CytRx Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.